Effect of Vojta Therapy on Covid-19 Respiratory Disease

NCT05031858 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2021-09-02

No results posted yet for this study

Summary

Vojta therapy is a physiotherapy intervention with scientific evidence in respiratory pathologies in children and proven in adults. In this pilot study with an RCT design, its effect in adult patients with respiratory pathology caused by the SARS-CoV-2 virus will be studied. The non-invasive and non-painful technique consists of applying tolerable pressure to specific areas of the patient's body. The objective is to activate, in a reflex way, the ventilatory physiology. It is compared with the conventional respiratory physiotherapy approach.

Conditions

  • COVID-19 Acute Respiratory Distress Syndrome

Interventions

OTHER

Respiratory physiotherapy

Respiratory physiotherapy

Sponsors & Collaborators

  • Hospital de Emergencias Enfermera Isabel Zendal de Madrid

    collaborator UNKNOWN
  • NUMEN Foundation

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-09-25
Primary Completion
2021-12-20
Completion
2022-04-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05031858 on ClinicalTrials.gov